Effectiveness and Safety of STYLAGE® L Lidocaïne in the Treatment of Nasolabial Folds

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 16, 2021

Primary Completion Date

January 13, 2022

Study Completion Date

July 6, 2022

Conditions
Aging
Interventions
DEVICE

STYLAGE® L Lidocaine

An injection of maximum 2 mL on one nasolabial fold is planned at Day 0. A touch-up of maximum 1 mL on the same nasolabial fold is possible 1 month after D0 (month 1).

DEVICE

Active control

An injection of maximum 2 mL on one nasolabial fold is planned at Day 0. A touch-up of maximum 1 mL on the same nasolabial fold is possible 1 month after D0 (month 1).

Trial Locations (2)

69100

Eurofins Dermscan Pharmascan, Villeurbanne

80-288

Eurofins Dermscan Poland, Gdansk

Sponsors
All Listed Sponsors
lead

Laboratoires Vivacy

INDUSTRY